Skip to content
triangle-white-good

A New Beginning: RWD and Non–Small-Cell Lung Cancer Patients

By David Hadley, Ph.D., Director of Data Quality and Analytics

FEATURED BLOG ARTICLE

A New Beginning: RWD and Non–Small-Cell Lung Cancer Patients

Share these Insights:

Craving Clarity And Transparency

For our inaugural “Transparency” post, our CEO Carla Balch sat down to outline her vision for Inteliquet and what she wants for patients and clinicians. Carla has worked with hundreds...
READ MORE

We are Inteliquet: A New Name for Clarity in Clinical Trials

Today, we are excited to announce that TransMed Systems is now Inteliquet. We have rebranded our growing organization to better reflect our mission of improving the way clinical trials work...
READ MORE

Stay up-to-date on the latest industry news, and innovations impacting clinical trials